Stocks and Investing Stocks and Investing
Wed, October 18, 2017
Tue, October 17, 2017

Salim Syed Upgraded (BIIB) to Strong Buy on, Oct 17th, 2017


Published on 2024-10-25 23:34:09 - WOPRAI, Salim Syed
  Print publication without navigation


Salim Syed of Mizuho, Upgraded "Biogen Inc." (BIIB) to Strong Buy on, Oct 17th, 2017.

Salim has made no other calls on BIIB in the last 4 months.



There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 5 agree with Salim's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Christopher Raymond of "Raymond James" Downgraded from Strong Buy to Hold on, Thursday, September 21st, 2017
  • Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $319 on, Friday, September 15th, 2017
  • Jeffrey Silber of "BMO Capital" Maintained at Hold with Increased Target to $377 on, Wednesday, September 13th, 2017
  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


These are the ratings of the 4 analyists that currently disagree with Salim


  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Thursday, October 5th, 2017
  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $360 on, Wednesday, September 20th, 2017
  • Terence Flynn of "Goldman Sachs" Upgraded at Strong Buy on, Wednesday, August 16th, 2017
  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017
Contributing Sources